(Press-News.org) MINNEAPOLIS, June 14, 2024 — NMDPSM, a global nonprofit leader in cell therapy, and the CIBMTR® (Center for International Blood and Marrow Transplant Research®) announced interim results from the ACCESS trial as an oral abstract during the European Hematology Association (EHA) Annual Meeting in Madrid, Spain. The study demonstrated that adults with hematologic malignancies who received peripheral blood stem cell (PBSC) transplant from HLA-mismatched unrelated donors (MMUD) followed by post-transplant cyclophosphamide (PTCy) graft-versus-host-disease (GvHD) prophylaxis exhibited a 79% overall survival (OS), the primary endpoint of the study, with an encouraging 51% GvHD-free, relapse-free survival (GRFS) probability at one-year post transplant.
“Our goal is to discover how we can improve outcomes for all patients – extending their life and improving their quality of life,” said Antonio Jimenez Jimenez, M.D., Hematology & Oncology Specialist, Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, presenting author. “We are encouraged by these early findings, which strongly advocate for the inclusion of this innovative treatment approach for patients receiving PBSC from partially matched, unrelated donors.”
In addition to achieving very good OS and GRFS clinical endpoints, adult participants also exhibited low rates of severe acute and moderate to severe chronic GvHD, both at 9%. The NMDP-sponsored ACCESS trial, conducted through the CIBMTR — a research collaboration between the Medical College of Wisconsin and NMDP — enrolled 70 adult patients with blood cancers and disorders, including acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and acute lymphoblastic leukemia (ALL), from 13 participating transplant centers including Sylvester Comprehensive Cancer Center. All patients in this stratum received reduced intensity conditioning, most often fludarabine/melphalan (63%) or fludarabine/busulfan (20%), and PBSCs from donors matched at 5-7 of 8 HLA loci, predominantly at the 7/8 match level (67%).
Expanding Access to Transplant: NMDP-led Donor for All Research
NMDP’s network of transplant center partners, many of which participate in CIBMTR trials, are bringing new research to light that is challenging previously established stem cell transplantation science. NMDP’s Donor For All initiative includes several research efforts that aim to establish a new safe and effective approach for using MMUD transplants worldwide.
“Low likelihood of matched sibling donors and the substantial variance of matched, unrelated donor availability on international registries have historically hindered the likelihood of finding a suitable donor,” said ACCESS study co-author Steven M. Devine, M.D., Chief Medical Officer, NMDP; Senior Scientific Director, CIBMTR. “Our Donor For All research is expanding the definition of a suitable donor for patients without a fully matched donor. Through CIBMTR, we are developing innovative protocols to prevent GvHD and reduce risk for post-transplant complications in patients with hematologic malignancies.”
ACCESS builds upon findings from the first Donor for All trial, the groundbreaking NMDP-sponsored 15-MMUD study, which showed that PTCy was effective in decreasing risk for GvHD in adults with hematologic malignancies receiving bone marrow (BM) transplants from MMUD. Similar to ACCESS, 15-MMUD patients showed a one-year OS rate of 76% and exhibited a low rate of moderate / severe GvHD.
Enrolling now, the OPTIMIZE trial is evaluating whether a reduced dose of PTCy will safely and effectively prevent GvHD while reducing infection risk in patients with hematologic malignancies receiving PBSC HCT from MMUDs. Finally, a recent observational study by the CIBMTR presented at the 2024 Tandem Meetings, reported no discernable differences in OS or GRFS for adult patients with hematologic malignancies using MMUD HCT at an 8/8 or 7/8 HLA match level using PTCy GvHD prophylaxis.
2024 EHA Presentation Details
Oral Presentation (Abstract #S260)
Friday, June 14; 2:45-3:00 p.m. CEST; Room Hall Dali 2
Post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis following mismatched unrelated donor peripheral blood stem cell (PBSC) transplantation
Antonio Jimenez Jimenez, M.D.
About CIBMTR®
CIBMTR® (Center for International Blood and Marrow Transplant Research®) is a nonprofit research collaboration between NMDPSM, in Minneapolis, and the Medical College of Wisconsin, in Milwaukee. CIBMTR collaborates with the global scientific community to increase survival and enrich quality of life for patients. CIBMTR facilitates critical observational and interventional research through scientific and statistical expertise, a large network of centers, and a unique database of long-term clinical data for more than 675,000 people who have received hematopoietic cell transplantation and other cellular therapies. Learn more at cibmtr.org.
About NMDPSM
At NMDPSM, we believe each of us holds the key to curing blood cancers and disorders. As a global nonprofit leader in cell therapy, NMDP creates essential connections between researchers and supporters to inspire action and accelerate innovation to find life-saving cures. With the help of blood stem cell donors from the world’s most diverse registry and our extensive network of transplant partners, physicians and caregivers, we’re expanding access to treatment so that every patient can receive their life-saving cell therapy. NMDP. Find cures. Save lives. Learn more at nmdp.org.
###
CONTACT:
Erica Sevilla
NMDP
media@nmdp.org
END
Hamilton, ON (June 14, 2024) – A widely available drug helps prevent upper gastrointestinal bleeding in critically ill adults on a breathing machine, according to the results of a global study and meta-analysis led by researchers at McMaster University.
The research, published on June 14, 2024 in The New England Journal of Medicine and NEJM Evidence, investigated the effect of the gastric acid suppressant pantoprazole, which is primarily used to treat heartburn caused by gastroesophageal reflux disease (GERD).
Patients ...
In a breakthrough that could redefine tea crop protection, a new study has shed light on the genetic makeup of the tea grey geometrid, Ectropis grisescens. Through the re-sequencing of 43 genomes, scientists have mapped out the pest's population structure and its remarkable adaptation to tea crops, offering new avenues for managing this agricultural adversary.
Amidst the lush tea plantations, a microscopic menace looms—the tea grey geometrid, a pest that can decimate tea yields with its insatiable appetite. The economic and qualitative havoc wreaked by this insect has prompted an urgent call for innovative pest control solutions. However, the genomic secrets ...
About The Study: This repeated cross-sectional study found that past-year Papanicolaou testing rates were lower in 2022 than 2019, pointing to a need to increase access to screenings to prevent an uptick in cervical cancer incidence. Rural-vs-urban differences in 2022 indicate a need to specifically target rural females.
Corresponding Author: To contact the corresponding author, Tyrone F. Borders, Ph.D., email ty.borders@uky.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2024.17094)
Editor’s ...
Parrots, songbirds, and hummingbirds can learn to make new sounds. No-one knew, but New Zealand’s smallest bird, the rifleman or titipounamu, may have a rudimentary version of the same talent.
University of Auckland research into the bird is part of a rethinking of how and when vocal learning evolved in birds.
Scientists traditionally assumed birds were split into two groups - those which can learn sounds (parrots, songbirds, and hummingbirds) and those which can’t - but the study published in the scientific journal Communications Biology ...
In recent years, high-entropy carbide ceramics have received extensive attention and become another research focus in the high entropy materials field, which are also known as multi-component carbide ceramics. The multi-component carbide ceramics not only inherit the special properties of high-entropy materials brought by complex compositions, but also keep the advantages of transition metal carbide ceramics as a kind of ultra-high temperature ceramics (UHTCs), such as high melting point, high-temperature stability, high Young's modulus, high hardness, and ...
Curbing the confirmed human influence on the climate system and mitigating climate change require profound transformation of global energy system. In this context, modeling technical progress and innovation within Integrated Assessment Models (IAMs) is crucial for providing insights about the consequences of long-term energy system transformation, and capturing the development of several interacting systems and technical evolution process.
A review of Endogenous Technological Change (ETC) written by Hongbo Duan ...
INDIANAPOLIS – The Indiana Sickle Cell Dashboard, launching this month on the Regenstrief Institute website, presents a dynamic, panoptic picture of sickle cell disease throughout an entire state. The new dashboard uses de-identified data from throughout the state of Indiana, obtained from multiple clinical and administrative sources, to present easy-to-understand, interactive visualizations of the disease’s prevalence and burden.
The pioneering dashboard, created, developed and maintained by the Regenstrief Institute, is one of the first ...
Synthetically generated population data can reveal the equity impacts of distributing transportation resources and funding across diverse regions, according to new research from NYU's Tandon School of Engineering that uses New York State as a case study.
Relying on an artificial dataset representing 19.5 million New York residents and over 120,000 modeled origin-destination trips, researchers from NYU Tandon's C2SMARTER, a Tier 1 U.S U.S. Department of Transportation-funded University Transportation Center, determined how best to invest in transportation services when equitable benefits are an objective.
They ...
In a new study, published in Social Psychological and Personality Science, researchers share evidence that people’s attitudes are deeply woven into language and culture across the globe and centuries.
The researchers looked at connections between people’s attitudes and language from 55 different topics like rich vs. poor, dogs vs. cats, or love vs. money. They used four text sources: Current English writing and text, English books going back 200 years, and texts in 53 languages other than English. As a measure of people’s attitudes, they used data from over 100,000 Americans; first, direct self-reports, and second, an indirect ...
Pregnant women who have been vaccinated against Covid-19 are less likely to have a caesarean section or experience hypertension, according to a study.
A meta-analysis funded by the National Institute for Health and Care Research Birmingham Biomedical Research Centre of 67 studies which included more than 1.8m women found that being fully vaccinated against COVID-19 had a protective benefit against infection and hospitalisation, while vaccination with at least one dose lowered the risk of adverse pregnancy-related and neonatal outcomes.
Drawing on ...
